These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study. Aboumatar S; Ferrari L; Stern S; Wade CT; Weingarten M; Connor GS; Rosenfeld WE Epilepsy Res; 2024 Feb; 200():107306. PubMed ID: 38340681 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study. Rosenfeld WE; Nisman A; Ferrari L Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894 [TBL] [Abstract][Full Text] [Related]
9. Effect of carbamazepine on EEG background activity and on interictal epileptiform abnormalities in focal epilepsy. Marciani MG; Gigli GL; Stefanini F; Sabbadini M; Stefani N; Maschio MC; Orlandi L; Bernardi G Int J Neurosci; 1993 May; 70(1-2):107-16. PubMed ID: 8083017 [TBL] [Abstract][Full Text] [Related]
10. Patterns of anti-seizure medication (ASM) use in pediatric patients with surgically managed epilepsy: A retrospective review of data from Boston Children's Hospital. Wang S; Rotenberg A; Bolton J Epilepsy Res; 2020 Feb; 160():106257. PubMed ID: 32004867 [TBL] [Abstract][Full Text] [Related]
11. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures. Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010 [TBL] [Abstract][Full Text] [Related]
12. Impact of antiseizure medication with a very long half-life on long term video-EEG monitoring in focal epilepsy. Hampel KG; Morata-Martínez C; Garcés-Sánchez M; Villanueva V Seizure; 2024 Feb; 115():100-108. PubMed ID: 38158320 [TBL] [Abstract][Full Text] [Related]
13. Identifying the cortical substrates of interictal epileptiform activity in patients with extratemporal epilepsy: An EEG-fMRI sequential analysis and FDG-PET study. Donaire A; Capdevila A; Carreño M; Setoain X; Rumià J; Aparicio J; Campistol J; Padilla N; Sanmartí F; Vernet O; Pintor L; Boget T; Ortells J; Bargalló N Epilepsia; 2013 Apr; 54(4):678-90. PubMed ID: 23362864 [TBL] [Abstract][Full Text] [Related]
14. Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy. Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Cerulli Irelli E; Chiesa V; Dainese F; De Maria G; Didato G; Di Gennaro G; Falcicchio G; Fanella M; Ferlazzo E; Gangitano M; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pizzanelli C; Pulitano P; Ranzato F; Rosati E; Tassi L; Di Bonaventura C; Epilepsia; 2023 Nov; 64(11):2922-2933. PubMed ID: 38079181 [TBL] [Abstract][Full Text] [Related]
16. Topiramate: effect on EEG interictal abnormalities and background activity in patients affected by focal epilepsy. Placidi F; Tombini M; Romigi A; Bianchi L; Izzi F; Sperli F; Mattia D; Cervellino A; Marciani MG Epilepsy Res; 2004 Jan; 58(1):43-52. PubMed ID: 15066674 [TBL] [Abstract][Full Text] [Related]
17. Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures. Glass HC; Soul JS; Chang T; Wusthoff CJ; Chu CJ; Massey SL; Abend NS; Lemmon M; Thomas C; Numis AL; Guillet R; Sturza J; McNamara NA; Rogers EE; Franck LS; McCulloch CE; Shellhaas RA JAMA Neurol; 2021 Jul; 78(7):817-825. PubMed ID: 34028496 [TBL] [Abstract][Full Text] [Related]
18. Etiology-specific response to antiseizure medication in focal epilepsy. Doerrfuss JI; Kowski AB; Holtkamp M Epilepsia; 2021 Sep; 62(9):2133-2141. PubMed ID: 34328218 [TBL] [Abstract][Full Text] [Related]
19. Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure. Fairclough S; Goodden J; Chumas P; Mathew R; Maguire M Epilepsia; 2023 Apr; 64(4):857-865. PubMed ID: 36636895 [TBL] [Abstract][Full Text] [Related]
20. Adjunctive cenobamate in highly active and ultra-refractory focal epilepsy: A "real-world" retrospective study. Peña-Ceballos J; Moloney PB; Munteanu T; Doyle M; Colleran N; Liggan B; Breen A; Murphy S; El-Naggar H; Widdess-Walsh P; Delanty N Epilepsia; 2023 May; 64(5):1225-1235. PubMed ID: 36790345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]